EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proton pump inhibitors modulate esophageal epithelial barrier function and crosstalk with eosinophils

Ravi Gautam iD, Megha Lal iD, Margaret C Carroll, Zoe Mrozek, Tina Trachsel, Jarad Beers, Melanie A Ruffner iD

Pediatric Allergy and Immunology · 2026-03 · 37 (3)

DOI: 10.1111/pai.70315 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Allergy and Immunology, online erschienen am 27.02.2026. Verfasst von Ravi Gautam und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Eosinophils, Eosinophilic Esophagitis, Omeprazole. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, American Academy of Allergy, Asthma and Immunology Foundation, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Eosinophilic esophagitis (EoE) is a chronic allergic disorder driven by type 2 inflammation, characterized by eosinophilic infiltration and esophageal epithelial abnormalities, including barrier dysfunction, basal cell hyperplasia, epithelial thickening, and loss of differentiation. Although proton pump inhibitor (PPI) therapy is frequently employed in the management of EoE and is known to reduce esophageal eosinophilia, improve barrier function, and exert anti‐inflammatory effects, the precise mechanism by which PPIs modulate type 2 inflammation and epithelial integrity remains incompletely understood.

Methods

Air‐liquid interface culture of esophageal epithelial cells was used to investigate the impact of the PPI omeprazole on barrier integrity in IL‐13‐treated cultures. Epithelial chemokine secretion was assessed following stimulation with IL‐13 and omeprazole, and eosinophil migration from healthy human donors was evaluated using 3 μm pore‐sized transwells. A co‐culture system of epithelial cells and eosinophils was used to examine chemokine secretion, eosinophil adhesion, and activation marker expression.

Results

Omeprazole treatment of IL‐13‐treated air‐liquid interface (ALI) cultures restored barrier integrity compared with IL‐13‐treated ALI cultures and resulted in 186 differentially expressed genes. Omeprazole treatment reduced STAT6 phosphorylation, downregulated calpain 14 expression, and upregulated desmoglein‐1 in IL‐13‐treated ALI samples. IL‐13 treatment induced upregulation of Eotaxin‐3, CXCL10, and periostin, which were downregulated by omeprazole. Eosinophils co‐cultured with human esophageal epithelial cells in the presence of omeprazole had diminished CD11b, CD18, and CD69 expression compared to those cultured with IL‐13 alone, and less eotaxin‐3, CXCL10, CCL2, and CCL4 were recovered from the co‐culture media.

Conclusion

Omeprazole diminished the effects of IL‐13 in both the epithelial air‐liquid interface model and eosinophil‐epithelial co‐cultures, alleviating barrier dysfunction, chemokine expression, and the upregulation of eosinophil adhesion markers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton Pump InhibitorsEosinophilsEosinophilic EsophagitisOmeprazoleEpithelial CellsEsophageal MucosaHumansInterleukin-13Coculture TechniquesCells, CulturedChemokinesSTAT6 Transcription FactorCell Adhesion

Stichwörter der Autor:innen

chemokineeosinophileosinophilic esophagitisepithelial barrierproton pump inhibitor

Substanzen

Proton Pump InhibitorsOmeprazoleInterleukin-13ChemokinesSTAT6 Transcription Factor

Autor:innen und Institutionen

  • Division of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Division of Allergy, University Children's Hospital Zurich, Zurich, Switzerland.
  • Department of Pediatrics, Perelman School of Medicine at University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Ravi Gautam, Megha Lal, Melanie A Ruffner

Förderung

  • NIDDK NIH HHS
  • American Academy of Allergy, Asthma and Immunology Foundation
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Gautam, R., Lal, M., Carroll, M. C., Mrozek, Z., Trachsel, T., Beers, J., & Ruffner, M. A. (2026). Proton pump inhibitors modulate esophageal epithelial barrier function and crosstalk with eosinophils. Pediatric Allergy and Immunology, 37(3). https://doi.org/10.1111/pai.70315

Vancouver

Gautam R, Lal M, Carroll MC, Mrozek Z, Trachsel T, Beers J, et al. Proton pump inhibitors modulate esophageal epithelial barrier function and crosstalk with eosinophils. Pediatric Allergy and Immunology. 2026;37(3). doi:10.1111/pai.70315

BibTeX
@article{Gautam2026,
  author = {Gautam, Ravi and Lal, Megha and Carroll, Margaret C and Mrozek, Zoe and Trachsel, Tina and Beers, Jarad and Ruffner, Melanie A},
  title = {Proton pump inhibitors modulate esophageal epithelial barrier function and crosstalk with eosinophils},
  journal = {Pediatric Allergy and Immunology},
  year = {2026},
  volume = {37},
  number = {3},
  doi = {10.1111/pai.70315}
}
Kostenlos starten →